Endothelial protein C receptor polymorphisms and risk of severe sepsis in critically ill patients

Intensive Care Medicine

Volumn 39, Issue 10, 2013, Pages 1752-1759

  Vassiliou, Alice G ^a   Maniatis, Nikolaos A ^a   Kotanidou, Anastasia ^a   Kallergi, Marina ^a   Karystinaki, Foteini S ^a   Letsiou, Eleftheria ^a   Glynos, Constantinos ^a   Kopterides, Petros ^a   Vassiliadi, Dimitra ^a   Nikitas, Nikitas ^a   Dimopoulou, Ioanna ^a   Armaganidis, Apostolos ^a   Orfanos, Stylianos E ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Critically ill; EPCR; Haplotypes; Septic shock; Severe sepsis

Indexed keywords

ENDOTHELIAL PROTEIN C RECEPTOR;

ADULT; AGE; ALLELE; APACHE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GENOTYPE; GREECE; HAPLOTYPE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; RISK; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; APACHE; CRITICAL ILLNESS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GREECE; HAPLOTYPES; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN C; RECEPTORS, CELL SURFACE; RISK ASSESSMENT; SEPSIS; SHOCK, SEPTIC; YOUNG ADULT;

EID: 84884587001     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-013-3018-5     Document Type: Article

References (40)

1. Angus DC, Wax RS (2001) Epidemiology of sepsis: an update. Crit Care Med 29:S109-S116
2. Levy MM, Dellinger RP, Townsend SR, Linde-Zwirble WT, Marshall JC, Bion J, Schorr C, Artigas A, Ramsay G, Beale R, Parker MM, Gerlach H, Reinhart K, Silva E, Harvey M, Regan S, Angus DC (2010) The surviving sepsis campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Intensive Care Med 36:222-231
3. SAFE Study Investigators, Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R (2011) Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 37:86-96
4. Balk RA, Bone RC (1989) The septic syndrome. Definition and clinical implications. Crit Care Clin 5:1-8
5. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb S, Beale RJ, Vincent JL, Moreno R, The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup (2013) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 39:165-228
6. Orfanos SE, Maniatis NA, Kotanidou A (2008) The effects of activated protein C on the septic syndrome. In: Vincent J-L (ed) Yearbook of intensive care and emergency medicine. Springer, Berlin, Heidelberg, New York, pp 721-729
7. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743-4746
8. Brueckmann M, Horn S, Lang S, Fukudome K, Schulze Nahrup A, Hoffmann U, Kaden JJ, Borggrefe M, Haase KK, Huhle G (2005) Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1. Thromb Haemost 93:743-750
9. Mosnier LO, Yang XV, Griffin JH (2007) Activated protein C mutant with minimal anticoagulant activity, normal cytoprotective activity, and preservation of thrombin activable fibrinolysis inhibitor-dependent cytoprotective functions. J Biol Chem 282:33022-33033
10. Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, Ferrell GL, Esmon CT (1996) The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci USA 93:10212-10216
11. Crawley JT, Gu JM, Ferrell G, Esmon CT (2002) Distribution of endothelial cell protein C/activated protein C receptor (EPCR) during mouse embryo development. Thromb Haemost 88:259-266
12. Fukudome K, Esmon CT (1994) Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269:26486-26491
13. Galligan L, Livingstone W, Volkov Y, Hokamp K, Murphy C, Lawler M, Fukudome K, Smith O (2001) Characterization of protein C receptor expression in monocytes. Br J Haematol 115:408-414
14. Laszik Z, Mitro A, Taylor FB Jr, Ferrell G, Esmon CT (1997) Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation 96:3633-3640
15. Scheffer GL, Flens MJ, Hageman S, Izquierdo MA, Shoemaker RH, Scheper RJ (2002) Expression of the vascular endothelial cell protein C receptor in epithelial tumour cells. Eur J Cancer 38:1535-1542
16. Sturn DH, Kaneider NC, Feistritzer C, Djanani A, Fukudome K, Wiedermann CJ (2003) Expression and function of the endothelial protein C receptor in human neutrophils. Blood 102:1499-1505
17. Taylor FB Jr, Stearns-Kurosawa DJ, Kurosawa S, Ferrell G, Chang AC, Laszik Z, Kosanke S, Peer G, Esmon CT (2000) The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood 95:1680-1686
18. Zheng X, Li W, Song Y, Hu Y, Ferrell GL, Esmon NL, Esmon CT (2007) Non-hematopoietic EPCR regulates the coagulation and inflammatory responses during endotoxemia. J Thromb Haemost 5:1394-1400
19. Biguzzi E, Merati G, Liaw PC, Bucciarelli P, Oganesyan N, Qu D, Gu JM, Fetiveau R, Esmon CT, Mannucci PM, Faioni EM (2001) A 23 bp insertion in the endothelial protein C receptor (EPCR) gene impairs EPCR function. Thromb Haemost 86:945-948
20. Saposnik B, Reny JL, Gaussem P, Emmerich J, Aiach M, Gandrille S (2004) A haplotype of the EPCR gene is associated with increased plasma levels of sEPCR and is a candidate risk factor for thrombosis. Blood 103:1311-1318
21. Uitte de Willige S, Van Marion V, Rosendaal FR, Vos HL, de Visser MC, Bertina RM (2004) Haplotypes of the EPCR gene, plasma sEPCR levels and the risk of deep venous thrombosis. J Thromb Haemost 2:1305-1310
22. Chen XD, Tian L, Li M, Jin W, Zhang HK, Zheng CF (2011) Relationship between endothelial cell protein C receptor gene 6936A/G polymorphisms and deep venous thrombosis. Chin Med J (Engl) 124:72-75
23. Galligan L, Powell C, Livingstone W, Mynett-Johnston L, Smith OP (2002) The G7763C endothelial protein C receptor (EPCR) gene mutation: prevalence and association with DVT in the Irish population. Thromb Haemost 88:163-165
24. Medina P, Navarro S, Corral J, Zorio E, Roldan V, Estelles A, Santamaria A, Marin F, Rueda J, Bertina RM, Espana F (2008) Endothelial protein C receptor polymorphisms and risk of myocardial infarction. Haematologica 93:1358-1363
25. Medina P, Navarro S, Estelles A, Espana F (2007) Polymorphisms in the endothelial protein C receptor gene and thrombophilia. Thromb Haemost 98:564-569
26. Medina P, Navarro S, Estelles A, Vaya A, Bertina RM, Espana F (2005) Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden. Thromb Haemost 94:389-394
27. Navarro S, Medina P, Mira Y, Estelles A, Villa P, Ferrando F, Vaya A, Bertina RM, Espana F (2008) Haplotypes of the EPCR gene, prothrombin levels, and the risk of venous thrombosis in carriers of the prothrombin G20210A mutation. Haematologica 93:885-891
28. -(1992) American College of Chest Physicians/Society of Critical Care Medicine consensus conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874
29. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European consensus conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818-824
30. Livak KJ (1999) Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149
31. Liaw PC, Neuenschwander PF, Smirnov MD, Esmon CT (2000) Mechanisms by which soluble endothelial cell protein C receptor modulates protein C and activated protein C function. J Biol Chem 275:5447-5452
32. Kurosawa S, Stearns-Kurosawa DJ, Hidari N, Esmon CT (1997) Identification of functional endothelial protein C receptor in human plasma. J Clin Invest 100:411-418
33. Sipahi T, Pocan H, Akar N (2006) Effect of various genetic polymorphisms on the incidence and outcome of severe sepsis. Clin Appl Thromb Hemost 12:47-54
34. Taylor FB Jr, Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE (1987) Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 79:918-925
35. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr, Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699-709
36. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S, Gårdlund B, Marshall JC, Rhodes A, Artigas A, Payen D, Tenhunen J, Al-Khalidi HR, Thompson V, Janes J, Macias WL, Vangerow B, Williams MD, PROWESS-SHOCK Study Group (2012) Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 366:2055-2064
37. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 34:17-60
38. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE (2001) Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 28:389-392
39. Sutherland AM, Walley KR (2009) Bench-to-bedside review: association of genetic variation with sepsis. Crit Care 13:210
40. Villar J, Maca-Meyer N, Perez-Mendez L, Flores C (2004) Bench-to-bedside review: understanding genetic predisposition to sepsis. Crit Care 8:180-189